Antiverse raises £3.5m to advance GenAI antibody design platform

Quick Summary:

Antiverse, a BioTech company designing antibodies for challenging targets, has added £3.5 million to its seed funding round.

These libraries are designed by using structural and sequence data to generate a library with high confidence against the target.

Lastly, Antiverse has opened new facilities in Boston, MA, and Prague, Czech Republic, demonstrating its expansion.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Jonathan Symcox

Category: InvestingBusiness

Markets: United KingdomCzech Republic

Topics: Investment MedTech

Source Website Secure: Yes (HTTPS)

News Sentiment: Negative

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-10-15 @ 23:35:10 (1 days ago)

News Timezone: GMT +8:00

News Source URL: businesscloud.co.uk

Language: English

Article Length: 325 words

Reading Time: 2 minutes read

Sentences: 15 lines

Sentence Length: 22 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © BusinessCloud

News ID: 23081029

View Article Analysis

About BusinessCloud

Main Topics: InvestingBusiness

Official Website: businesscloud.co.uk

Year Established: 2016

Headquarters: United Kingdom

News Last Updated: 1 days ago

Coverage Areas: United Kingdom

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #61

Publisher Details

Frequently Asked Questions